Since low-tumor-infiltration patients displayed a high level of pre-exhausted CD8+ T cells compared to high-tumor-infiltration ones, we speculate that lower-tumor infiltration WM patients would respond well to immune therapies such as anti-PD-L1 antibodies according to Kallies et al. [51] report. Here, CD8A is linked to neoplasm.